Physician profile
Brian Ang
NPI 1538327598
$945.94
in general payments reported to CMS, 2019-2025
5 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $137 · 2022: $74.18 · 2023: $407 · 2024: $21.97 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493 · Travel and Lodging: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $493.11 |
| Travel and Lodging | $242.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $338.25 | 2022-2024 | Everest Spinal System, T2 Alpha |
| Polynovo North America LLC | $194.56 | 2025 | Novosorb Btm |
| Abbvie INC. | $165.08 | 2023 | Durysta, Xen Glaucoma Treatment System |
| Heron Therapeutics, INC. | $136.55 | 2021 | |
| Globus Medical, INC. | $111.50 | 2025 | Anthem |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.